(Q39331269)

11 September 2017

title

Effect of omalizumab on patients with chronic urticaria (English)

1 reference

11 September 2017

0 references

1 reference

1 reference

Sheldon L Spector

1

1 reference

11 September 2017

Ricardo A Tan

series ordinal

2

1 reference

11 September 2017

publication date

1 August 2007

1 reference

Annals of Allergy, Asthma & Immunology

11 September 2017

published in

1 reference

11 September 2017

volume

99

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

190-193

1 reference

Antileukotrienes in chronic urticaria

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

1 reference

7 January 2021

Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

Complement dependence of histamine release in chronic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

Chronic urticaria sera increase basophil CD203c expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

Mechanisms of autoimmune activation of basophils in chronic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

Omalizumab for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

Omalizumab-induced reductions in mast cell Fce psilon RI expression and function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

Chronic urticaria: pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

The extent and nature of disability in different urticarial conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960644-8

7 January 2021

10.1016/S1081-1206(10)60644-8

Identifiers

DOI

1 reference

release_fk5uzqscn5d4hdvxgjqgtascne

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fk5uzqscn5d4hdvxgjqgtascne

24 November 2022

mapped directly with Wikidata item

1 reference